BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors
Reisländer T., Lombardi EP., Groelly FJ., Miar A., Porru M., Di Vito S., Wright B., Lockstone H., Biroccio A., Harris A., Londoño-Vallejo A., Tarsounas M.